MOH Stock Analysis: Buy, Sell, or Hold?

MOH - Molina Healthcare, Inc.

HOSPITAL & MEDICAL SERVICE PLANS
$179.59
-5.34 (-2.89%) β–Ό
WAIT
LOW Confidence
Protect Your MOH Gains
Last Updated: January 30, 2026
Earnings: Feb 05, 2026 4d

Get Alerted When MOH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MOH is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$134.30
Based on -3.5% avg growth
INTRINSIC VALUE TODAY
$83.39
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: MOH is currently trading at $179.59, which is considered fair relative to its 30-day fair value range of $170.82 to $193.21. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.9) compared to its historical average (13.0). At these levels, the market is pricing in 4.7% annual earnings growth.

Technical Outlook: Technically, MOH is in a strong downtrend. The price is currently testing key support at $178.00. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Fair Price Range $170.82 - $193.21
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 71.0%

Protect Your Profits

Holding MOH? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($186.69)
  • BULLISH: Expecting earnings turnaround to 4.7% growth with 11.6% revenue growth
  • WARNING: Recommendation downgraded due to -11.0% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $170.82 - $193.21
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $178.00
Resistance Level $203.00
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 14.91
Wall Street Target $186.69 (+1.0%)
Revenue Growth (YoY) 11.6%
Earnings Growth (YoY) -73.4%
Profit Margin 2.1%
Valuation Premium vs History +4.7% premium
PE vs Historical 14.9 vs 13.0 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +4.7% (market-implied from PE analysis)
1-Year Target $193.62 (+5%)
2-Year Target $202.72 (+10%)
3-Year Target $212.25 (+15%)
3-Yr Target (if PE normalizes) (PE: 15β†’13) PE COMPRESSION $185.10 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: -10.9%) $201.68 (+9%)
Base: (SPY PE: 14.9, Growth: -10.9%) $134.81 (-27%)
Bear: (PE: 12.7, Growth: -10.9%) $114.59 (-38%)
πŸ“ˆ Valuation based on Current Earnings
Trailing PE: 11.52 | Current EPS (TTM): $16.23
Bull Case $157.23 (-12%)
Analyst growth -23.6%, PE expands to 12.7
Base Case $142.94 (-20%)
Market implied -23.6%, PE stable at 11.5
Bear Case $127.16 (-29%)
Severe decline -20.0%, PE contracts to 9.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 10:00 PM ET
Data refreshes hourly during market hours. Next update: 11:00 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
4
Buys
2
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ro Khanna BUY 2025-09-29
Byron Donalds SELL 2025-09-04
Ronna Romney SELL 700 shares 2025-08-06

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CVS
CVS Health Corp
STRONG BUY
28 analysts
$95 61 BUY
CI
Cigna Corp
STRONG BUY
25 analysts
$327 58 HOLD
UNH
UnitedHealth Group Incor…
STRONG BUY
27 analysts
$394 47 HOLD
ELV
Elevance Health Inc
STRONG BUY
22 analysts
$395 53 HOLD
HUM
Humana Inc
HOLD
26 analysts
$288 62 BUY

Advanced MOH Option Strategies

Professional options setups generated by AI based on today's MOH price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for MOH

MOH Technical Chart MOH Price Prediction MOH Earnings Date MOH Investment Advisor MOH Fair Price Analyzer MOH Options Advisor MOH Options Chain MOH Options Analysis MOH Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals